Mark Cuban,  Brian Forte

Mark Cuban wants NBA to consider allowing HGH use

27 Comments

Imagine a world where NBA players were banned from using exercise equipment.

The league didn’t want players getting too physically dominant and subjecting themselves to the types of muscle pulls that would come with a physique arms race. Players were still allowed to train, but using any outside equipment crossed the line. Of course, some players broke the rules and lifted weights, but they risked suspension.

Seem irrational?

That’s not all that different from the NBA’s HGH ban.

Perhaps, there’s good reason to prevent players from using HGH, but Mark Cuban wants to see the research first.

Sam Amick of USA TODAY:

Cuban isn’t advocating the use of the controversial drug but rather calling attention to what he sees as a dearth of research on the topic as it relates to athletes who are recovering from injury. His hope, which he shared in front of the league’s owners and league officials at an Oct. 23 Board of Governors meeting in New York, is that a more-informed decision can be made as to whether it should remain on the league’s banned-substance list or perhaps be utilized as a way of expediting an athlete’s return to the court. If it were ever allowed — and it’s safe to say that won’t be happening anytime soon — Cuban sees a major benefit for teams and their fans like.

“The issue isn’t whether I think it should be used,” Cuban told USA TODAY Sports via e-mail. “The issue is that it has not been approved for such use. And one of the reasons it hasn’t been approved is that there have not been studies done to prove the benefits of prescribing HGH for athletic rehabilitation or any injury rehabilitation that I’m aware of. The product has such a huge (public) stigma that no one wants to be associated with it.”

“I believe that professional sports leagues should work together and fund studies to determine the efficacy of HGH for rehabbing an injury,” Cuban told USA TODAY Sports. “Working together could lead us from the path of demonizing HGH and even testosterone towards a complete understanding. It could allow us to make a data based decision rather than the emotional decision we are currently making. And if it can help athletes recover more quickly, maybe we can extend careers and have healthier happier players and fans.”

I would not be surprised if Cuban is open to allowing HGH for all players, injured or not. But proposing a change as it relates to injuries is a good way in the door.

If the side effects are significant, HGH should remain banned. Players who don’t want to subject themselves to that risk shouldn’t have to compete with players who do.

But if the side effects are deemed mild and rare enough, what exactly would be the NBA’s basis for a continued ban? There are significant legal and perception challenges, but if the league has sound research supporting HGH use, those hurdles could be cleared in time.

I’m not sure we’ll ever see HGH allowed in the NBA. At minimum, it’s a long road to that date.

Cuban is just trying to take a few steps in that direction.

Reports: Boston interested in trade for Andrew Bogut, Mavericks not there. Yet.

LOS ANGELES, CA - NOVEMBER 08:  Andrew Bogut #6 of the Dallas Mavericks reacts to scoring during the second half of a game against the Los Angeles Lakers at Staples Center on November 8, 2016 in Los Angeles, California.NOTE TO USER: User expressly acknowledges and agrees that, by downloading and or using this photograph, User is consenting to the terms and conditions of the Getty Images License Agreement.  (Photo by Sean M. Haffey/Getty Images)
1 Comment

There has been speculation around the league that now that the Dallas Mavericks are struggling, there will be a sell-off. Harrison Barnes is a future lynchpin, Dirk Nowitzki isn’t going anywhere, but there are a lot of players that are more win-now than the place the Mavericks seem to be, so those guys could get moved for future assets.

At the top of the list: Andrew Bogut.

In a shock to nobody, there is a report that Boston would be interested, via A. Sherrod Blakely at CSNNE.com.

As the February trade deadline draws near, the Boston Celtics are expected to take a close look at adding a defensive-minded, rebounding big man with Dallas’ Andrew Bogut likely to emerge as a target.

The former No. 1 overall pick is the final year of a three-year, $36 million contract he signed with the Golden State Warriors in 2014. He is due to make $11.027 million in this, the last season of the contract.

Dallas (4-15) has the worst record in the NBA and are likely to continue building for a post-Dirk Nowitzki with a high lottery pick in June’s NBA draft. Adding another first-round pick from Boston would benefit a squad that has to increase its quality depth going forward. Having another first-round pick can only enhance their roster.

While you can see the logic from the outside, inside the Dallas’ offices they are not in that place, reports Tim MacMahon of ESPN.

Sources tell ESPN that Mavs have no immediate intention to shop C Andrew Bogut, as their focus, for now, is trying to salvage their season. However, Mavs management recognizes that Bogut has significant value in the trade market as a proven championship-caliber complementary piece in a contract year and could become motivated to move him if and when it becomes clear that the Mavs have no hope of making the playoffs this season. Several league sources said the Mavs should be able to get a first-round pick from a contender for Bogut.

Let’s be honest: Dallas isn’t making the playoffs. They can make their worst-in-the-West record look a little better — six of their next eight games are at home, at some point they will get Dirk Nowitzki back — but they are not climbing over six teams and making up the 11 games they are below .500 just to get in the mix for the potential eight seed.

Which means expect them to be looking for deals as the deadline nears, and Andrew Bogut may well get moved. But we’re going to get past Christmas before that talk starts to gain real traction.

PBT Podcast: Breaking down Eastern Conference standings with Dan Feldman

WASHINGTON, DC - NOVEMBER 11: LeBron James #23 of the Cleveland Cavaliers dunks against the Washington Wizards during the first half at Verizon Center on November 11, 2016 in Washington, DC. NOTE TO USER: User expressly acknowledges and agrees that, by downloading and or using this photograph, User is consenting to the terms and conditions of the Getty Images License Agreement. (Photo by Patrick Smith/Getty Images)
1 Comment

One-quarter of the way into the NBA season, we know a few things about the Eastern Conference.

As expected, the Cavaliers are the team to beat. Toronto has established itself as a clear second in line, but Boston is third and finally getting healthy. After that there are a lot of questions about who are playoff teams and who is going to slide. Will the Knicks hold on? Will Atlanta bounce back? Will the Bulls regress?

Kurt Helin and Dan Feldman of NBC Sports break it all down in this latest PBT podcast.

As always, you can check out the podcast below, or listen and subscribe via iTunes (check there to see all the NBC Sports podcasts), subscribe via the fantastic Stitcher app, check us out on Google play, or check out our new PBT podcast homepage and archive at Audioboom.com.

Report: Rockets match offer sheet, will keep Donatas Motiejunas

Donatas Motiejunas, Kenneth Faried
Leave a comment

Give the Brooklyn Nets front office credit, they tried. GM Sean Marks is being very creative trying to rebuild a team after his predecessor Billy King — on the orders of ownership — burned all future assets in hopes of having a good team to open the new Barclay’s center.

The Nets went after Houston big man Donatas Motiejunas with a creative four-year, $37 million offer sheet. It didn’t work, the Rockets matched, something first reported by Adrian Wojnarowski of The Vertical at Yahoo Sports and since confirmed by others.

To make room on the roster, the Rockets have waived Bobby Brown.

The match expected. The offer sheet was constructed so that if Motiejunas’ ongoing back issues are severe the Rockets can pay him $5 million for this season and be done — a move that is not likely. If they keep him past Jan. 10 of this season, they owe him another $3.5 million. There is a March deadline to pick up the $9 million for next season. More importantly, the last two years of this contract are not guaranteed, meaning there isn’t a lot of risk for the Rockets and the contract is very tradable. Which could happen next summer (because of how late in the year the deal was signed he cannot be traded this season).

There’s also a chance this signing just works out — on paper, Motiejunas is a good fit in the Mike D’Antoni system. He’s a big man who seasons ago he shot 36.8 percent from three — he can space the floor on James Harden drives, and in transition he could run to the arc or post up smaller defenders inside on a cross match. There’s a lot of potential there, he’s going to get some run.

Draymond Green’s agent, B.J. Armstrong: NBA changes rules to increase revenue, not improve quality of play

NEW ORLEANS - FEBRUARY 16:  NBA legend B.J. Armstrong participates in the Haier Shooting Stars competition, part of 2008 NBA All-Star Weekend at the New Orleans Arena on February 16, 2008 in New Orleans, Louisiana.  NOTE TO USER: User expressly acknowledges and agrees that, by downloading and or using this photograph, User is consenting to the terms and conditions of the Getty Images License Agreement.  (Photo by Chris Graythen/Getty Images)
Chris Graythen/Getty Images
4 Comments

Now that he got Donatas Motiejunas an offer sheet from the Nets, agent B.J. Armstrong can lodge back-in-my-day complaints on behalf of another client.

This time, it’s Draymond Green.

The Warriors forward has come under increased scrutiny for his unnatural acts, a new area of emphasis by the NBA’s competition committee. Green vigorously defended himself, but Armstrong goes even further.

Armstrong, via Sam Amick of USA Today:

“The fact that everyone is trying to cover their positions or justifying why they did what they did, the (league’s perspective) was kind of disappointing from this viewpoint: Since I’ve been a part of this league, I can’t recall when they’ve actually made rules that have actually helped to improve the game of basketball,” Armstrong, whose client was given a Flagrant-1 foul when he kicked Houston Rockets star James Harden on Thursday, told USA TODAY Sports by phone.

“Every move has been made with some motive, to make the game look a certain way, to speed the game up, to do all of these things. But what, when the competition committee — whoever those people are — what have they actually done to improve the game of basketball? … Not to put more people in the stands, not to make the game more appealing for people globally. What has been done to improve the game of basketball? That’s it. That’s it. That’s my only question.”

The competition committee is comprised of two owners, four general managers, three head coaches and a players-union representative.

To the bigger point: What improves the game of basketball? That’s such a subjective standard. Creating a pleasing product that appeals to customers seems like a good start. I sense Armstrong – who won three championships with the Bulls in the 1990s – believes it’s making the game look like when he played.

Yup, to Armstrong, those grind-it-out, clog-the-paint games of the 90s were preferable to today’s contest. And that’s a fine opinion. Even I have a fondness for those 90s games.

But most fans disagree, and the NBA is a business trying to attract fans – which makes Armstrong’s complaints absurd.

At least until you remember he’s just an agent sticking up for his client. Then, it all makes sense.